Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1238, 2009-01, pp. : 11-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Efalizumab/infliximab: CD8+ cutaneous T cell lymphoma (first report with efalizumab): 2 case reports
Reactions Weekly, Vol. 1, Iss. 1137, 2007-01 ,pp. :
Access to resources
Recommend
Efalizumab: T-cell clone proliferation: case report
Reactions Weekly, Vol. 1, Iss. 1354, 2011-01 ,pp. :
Mercaptopurine: Hepatosplenic T-cell lymphoma: case report
Reactions Weekly, Vol. 1, Iss. 1315, 2010-01 ,pp. :
Alemtuzumab: Cutaneous T cell lymphoma transformation in an elderly patient: case report
Reactions Weekly, Vol. 1, Iss. 1170, 2007-01 ,pp. :